Sandoz Fills Pipeline Gap With EirGenix Trastuzumab Deal

 
• By Aidan Fry
Pipeline
Sandoz has filled a gap in its biosimilars portfolio by partnering with EirGenix for trastuzumab • Source: Shutterstock

More from Biosimilars

More from Products